Krakow, Poland – 20 January 2020 – Ryvu Therapeutics scientists are the co-authors of a poster presentation on HIF-2alpha inhibitors presented by Merck at the 2nd Alpine Winter Conference on Medicinal and Synthetic Chemistry, taking place in St. Anton, Austria,  on January 19 – 23, 2020.

Additional information is available on the conference website at https://www.alpinewinterconference.org/